scholarly article | Q13442814 |
P50 | author | Zhenzhou Jiang | Q90304991 |
P2093 | author name string | Tao Wang | |
Chunjie Li | |||
Lei Zhao | |||
Luyong Zhang | |||
Jingwei Jiang | |||
Xiaofei Huang | |||
Lixin Sun | |||
Sijia Li | |||
Xihua Li | |||
Dengqiu Xu | |||
Zeren Sun | |||
P2860 | cites work | Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway | Q24302117 |
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size | Q24314330 | ||
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle | Q24538577 | ||
Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis | Q33640296 | ||
Transforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiation | Q33673668 | ||
Assessing functional performance in the mdx mouse model | Q34153862 | ||
NAD⁺ repletion improves mitochondrial and stem cell function and enhances life span in mice | Q34524174 | ||
Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesis | Q35096079 | ||
TGF-β1 induced transdifferentiation of rpe cells is mediated by TAK1. | Q35596508 | ||
TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid Hemorrhage | Q35925884 | ||
A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy | Q36179162 | ||
TAK1 modulates satellite stem cell homeostasis and skeletal muscle repair | Q36379442 | ||
Isolation and culture of individual myofibers and their satellite cells from adult skeletal muscle | Q36805017 | ||
Sarcolemma-localized nNOS is required to maintain activity after mild exercise | Q36987100 | ||
Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular Dystrophy | Q37246026 | ||
Pathological roles of MAPK signaling pathways in human diseases | Q37676393 | ||
Progress toward Gene Therapy for Duchenne Muscular Dystrophy | Q39246797 | ||
Apoptosis signal-regulating kinase 1 is an intracellular inducer of p38 MAPK-mediated myogenic signalling in cardiac myoblasts. | Q39550879 | ||
Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis. | Q39570413 | ||
TGF-β1 activates the canonical NF-κB signaling to promote cell survival and proliferation in dystrophic muscle fibroblasts in vitro | Q39999244 | ||
Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophy | Q40401831 | ||
TAK1 inhibition attenuates both inflammation and fibrosis in experimental pneumoconiosis | Q40976804 | ||
Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1. | Q42719528 | ||
Inhibiting TGF-β activity improves respiratory function in mdx mice | Q42732727 | ||
Mitochondrial fusion/fission process involved in the improvement of catalpol on high glucose-induced hepatic mitochondrial dysfunction | Q46705578 | ||
Role of transforming growth factor-β in muscle damage and regeneration: focused on eccentric muscle contraction | Q49287596 | ||
TAK1 regulates skeletal muscle mass and mitochondrial function | Q50130561 | ||
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic management | Q50207377 | ||
Interleukin-36α Induces Inflammatory Mediators From Human Pancreatic Myofibroblasts Via a MyD88 Dependent Pathway. | Q50947645 | ||
TAK1 mediates apoptosis via p38 involve in ischemia-induced renal fibrosis. | Q52585204 | ||
MiR-499 regulates myoblast proliferation and differentiation by targeting transforming growth factor β receptor 1 | Q57091417 | ||
Catalpol Inhibits Homocysteine-induced Oxidation and Inflammation via Inhibiting Nox4/NF-κB and GRP78/PERK Pathways in Human Aorta Endothelial Cells | Q57471151 | ||
Mitochondrial dysfunction and inhibition of myoblast differentiation in mice with high-fat-diet-induced pre-diabetes | Q58544760 | ||
Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and Therapy | Q60908818 | ||
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice | Q60912830 | ||
Catalpol prevents denervated muscular atrophy related to the inhibition of autophagy and reduces BAX/BCL2 ratio via mTOR pathway | Q60923753 | ||
Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugs | Q61919654 | ||
A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-beta | Q73668163 | ||
TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagen | Q79771332 | ||
MiR-149 suppresses the inflammatory response of chondrocytes in osteoarthritis by down-regulating the activation of TAK1/NF-κB | Q88014830 | ||
miR-22 regulates C2C12 myoblast proliferation and differentiation by targeting TGFBR1 | Q88193851 | ||
The role of oxymatrine in regulating TGF-β1 in rats with hepatic fibrosis | Q88398034 | ||
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019 | Q90985106 | ||
A new hypoglycemic mechanism of catalpol revealed by enhancing MyoD/MyoG-mediated myogenesis | Q91004843 | ||
Possible role of hepatic macrophage recruitment and activation in triptolide-induced hepatotoxicity | Q91260077 | ||
USP19 Inhibits TNF-α- and IL-1β-Triggered NF-κB Activation by Deubiquitinating TAK1 | Q92282023 | ||
Transforming Growth Factor β-Activated Kinase 1 Regulates Mesenchymal Stem Cell Proliferation Through Stabilization of Yap1/Taz Proteins | Q92954850 | ||
Adaptive homeostasis of the vitamin D-vitamin D nuclear receptor axis in 8-methoxypsoralen-induced hepatotoxicity | Q93007010 | ||
Featured characteristics and pivotal roles of satellite cells in skeletal muscle regeneration | Q93173658 | ||
P921 | main subject | Duchenne muscular dystrophy | Q1648484 |
P577 | publication date | 2020-08-31 | |
P1433 | published in | Journal of Cachexia, Sarcopenia and Muscle | Q6294897 |
P1476 | title | A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1 |
Q99557476 | Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathway | cites work | P2860 |
Search more.